Stocks and Investing Stocks and Investing
Wed, March 16, 2022
Tue, March 15, 2022
Mon, March 14, 2022
Fri, March 11, 2022

Yasmeen Rahimi Maintained (ALGS) at Buy with Increased Target to $375 on, Mar 11th, 2022


Published on 2024-10-27 20:02:44 - WOPRAI, Yasmeen Rahimi
  Print publication without navigation


Yasmeen Rahimi of Piper Sandler, Maintained "Aligos Therapeutics, Inc." (ALGS) at Buy with Increased Target from $1,175 to $375 on, Mar 11th, 2022.

Yasmeen has made no other calls on ALGS in the last 4 months.



There is 1 other peer that has a rating on ALGS. Out of the 1 peers that are also analyzing ALGS, all agrees with Yasmeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eric Joseph of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $300 on, Friday, January 7th, 2022